Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield

Neurobiology of Aging

Volumn 35, Issue 3, 2014, Pages 532-536

  Takamura, Yusaku ^a   Ono, Kenjiro ^b   Matsumoto, Jumpei ^a   Yamada, Masahito ^b   Nishijo, Hisao ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; FEPSP; LTD; LTP; Oligomeric amyloid ; Photo cross linked oligomeric amyloid ; Synaptic plasticity; T 817MA

Indexed keywords

1 [3 [2 (1 BENZOTHIOPHEN 5 YL)ETHOXY]PROPYL]AZETIDIN 3 OL MALEATE; AMYLOID BETA PROTEIN[1-42]; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; GEL PERMEATION CHROMATOGRAPHY; HIPPOCAMPAL CA1 REGION; INHIBITION KINETICS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; FEPSP; LTD; LTP; OLIGOMERIC AMYLOID-Β; PHOTO-CROSS-LINKED OLIGOMERIC AMYLOID-Β; SYNAPTIC PLASTICITY; T-817MA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ATROPHY; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; LONG-TERM POTENTIATION; MALE; MALEATES; MICE; MICE, INBRED C57BL; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; SYNAPSES; THIOPHENES;

EID: 84889560474     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.08.037     Document Type: Article

References (23)

1. Barnes S.J., Opitz T., Merkens M., Kelly T., von der Brelie C., Krueppel R., Beck H. Stable mossy fiber long-term potentiation requires calcium influx at the granule cell soma, protein synthesis, and microtubule-dependent axonal transport. J.Neurosci. 2010, 30:12996-13004.
2. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 2005, 8:79-84.
3. Hirata K., Yamaguchi H., Takamura Y., Takagi A., Fukushima T., Iwakami N., Saitoh A., Nakagawa M., Yamada T. Anovel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-β-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons. J.Pharmacol. Exp. Ther. 2005, 314:252-259.
4. Hirata, K., Sugimori, M., Llinas, R.R., 2008. Effect of T-817MA on 1-methyl-4-phenylpyridinium (MPP+) and amyloid β (Aβ) induced dying-back degeneration in primary culture of rat cortical neurons. Annual Meeting of Society for Neuroscience 247.16/S11.
5. Hu Y.S., Xu P., Pigino G., Brady S.T., Larson J., Lazarov O. Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice. FASEB J. 2010, 24:1667-1681.
6. Kimura T., Hong Nguyen P.T., Ho S.A., Tran A.H., Ono T., Nishijo H. T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-β peptide. Br. J. Pharmacol. 2009, 157:451-463.
7. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A 1998, 95:6448-6453.
8. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
9. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 1999, 155:853-862.
10. Moreno H., Choi S., Yub E., Brusco J., Avila J., Moreira J.E., Sugimori M., Llinás R.R. Blocking effects of human tau on squid giant synapse transmission and its prevention by T-817 MA. Front. Synaptic Neurosci. 2011, 3:3.
11. Muresan V., Muresan Z. Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?. Future Neurol. 2009, 4:761-773.
12. Nguyen P.T., Kimura T., Ho S.A., Tran A.H., Ono T., Nishijo H. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-β peptide (1-40) in rats. Hippocampus 2007, 17:443-455.
13. Oda T., Wals P., Osterburg H.H., Johnson S.A., Pasinetti G.M., Morgan T.E., Rozovsky I., Stine W.B., Snyder S.W., Holzman T.F., Krafft G.A., Finch C.E. Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp. Neurol. 1995, 136:22-31.
14. Ong K.C., Khoo H.E. Biological effects of myricetin. Gen. Pharmacol. 1997, 29:121-126.
15. Ono K., Condron M.M., Teplow D.B. Structure-neurotoxicity relationships of amyloid β-protein oligomers. Proc. Natl. Acad. Sci. U.S.A 2009, 106:14745-14750.
16. Ono K., Condron M.M., Teplow D.B. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity. J.Biol. Chem. 2010, 285:23186-23197.
17. Ono K., Li L., Takamura Y., Yoshiike Y., Zhu L., Han F., Mao X., Ikeda T., Takasaki J., Nishijo H., Takashima A., Teplow D.B., Zagorski M.G., Yamada M. Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding. J.Biol. Chem. 2012, 287:14631-14643.
18. Pigino G., Morfini G., Atagi Y., Deshpande A., Yu C., Jungbauer L., LaDu M., Busciglio J., Brady S. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc. Natl. Acad. Sci. U.S.A 2009, 106:5907-5912.
19. Roher A.E., Chaney M.O., Kuo Y.M., Webster S.D., Stine W.B., Haverkamp L.J., Woods A.S., Cotter R.J., Tuohy J.M., Krafft G.A., Bonnell B.S., Emmerling M.R. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 1996, 271:20631-20635.
20. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
21. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-[beta] protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14. 837-42.
22. Tomiyama T., Nagata T., Shimada H., Teraoka R., Fukushima A., Kanemitsu H., Takuma H., Kuwano R., Imagawa M., Ataka S., Wada Y., Yoshioka E., Nishizaki T., Watanabe Y., Mori H. Anew amyloid β variant favoring oligomerization in Alzheimer's-type dementia. Ann. Neurol. 2008, 63:377-387.
23. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation invivo. Nature 2002, 416:535-539.